Rock Point Advisors LLC Has $656,000 Holdings in American Well Corporation $AMWL

Rock Point Advisors LLC decreased its holdings in American Well Corporation (NYSE:AMWL) by 48.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 133,584 shares of the company’s stock after selling 125,587 shares during the period. Rock Point Advisors LLC’s holdings in American Well were worth $656,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in AMWL. Headlands Technologies LLC acquired a new position in shares of American Well in the 2nd quarter valued at about $39,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of American Well in the 3rd quarter valued at about $62,000. Prelude Capital Management LLC acquired a new position in shares of American Well in the 3rd quarter valued at about $86,000. Engineers Gate Manager LP acquired a new position in shares of American Well in the 2nd quarter valued at about $101,000. Finally, JPMorgan Chase & Co. grew its stake in shares of American Well by 16.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company’s stock valued at $131,000 after buying an additional 2,081 shares in the last quarter. Institutional investors and hedge funds own 56.05% of the company’s stock.

American Well Trading Down 3.7%

Shares of NYSE AMWL opened at $7.85 on Wednesday. The business has a fifty day simple moving average of $5.91 and a 200 day simple moving average of $5.11. The firm has a market capitalization of $129.85 million, a price-to-earnings ratio of -1.45 and a beta of 1.52. American Well Corporation has a one year low of $3.71 and a one year high of $9.15.

American Well (NYSE:AMWL) last issued its earnings results on Tuesday, May 5th. The company reported ($0.66) EPS for the quarter, beating analysts’ consensus estimates of ($0.77) by $0.11. The business had revenue of $54.88 million during the quarter, compared to analyst estimates of $51.54 million. American Well had a negative return on equity of 32.11% and a negative net margin of 37.02%. On average, research analysts anticipate that American Well Corporation will post -2.68 earnings per share for the current fiscal year.

Insider Transactions at American Well

In other American Well news, insider Dmitry Zamansky sold 5,575 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total transaction of $29,547.50. Following the completion of the transaction, the insider directly owned 241,080 shares in the company, valued at $1,277,724. This represents a 2.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold 9,664 shares of company stock worth $51,219 in the last three months. Corporate insiders own 12.80% of the company’s stock.

Analyst Upgrades and Downgrades

AMWL has been the subject of several recent research reports. Wall Street Zen raised American Well from a “sell” rating to a “hold” rating in a research note on Sunday, March 22nd. Morgan Stanley boosted their price target on American Well from $6.00 to $6.50 and gave the company an “equal weight” rating in a research note on Wednesday, May 6th. TD Cowen boosted their price target on American Well from $5.00 to $8.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Stifel Nicolaus decreased their target price on American Well from $6.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Well in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $7.30.

American Well Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.